The Business Model of Recursion Pharmaceuticals, Inc.
As of August 3, 2026
Recursion Pharmaceuticals, Inc., commonly known as Recursion, is a clinical-stage TechBio company headquartered in Salt Lake City, Utah. The company develops investigational medicines across areas including oncology, rare disease, neuroscience, and immunology.
Its Recursion OS is an AI-native drug-discovery and development platform that integrates biology, chemistry, clinical development, proprietary multimodal data, automated laboratory experimentation, and purpose-built machine-learning models. Recursion was founded on November 5, 2013, and its Class A common stock trades on Nasdaq under the symbol RXRX.
Hard Facts
Business Model Canvas
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for freeBusiness Model Patterns
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for free
SWOT Analysis
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for freeWhat makes Recursion Pharmaceuticals, Inc. special?
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for freeMarketing Insights
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for free